- Home
- NML vs TECH Comparison
NML vs TECH Comparison
Compare NML & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NML
- TECH
- Stock Information
- Founded
- NML 2012
- TECH 1976
- Country
- NML United States
- TECH United States
- Employees
- NML N/A
- TECH N/A
- Industry
- NML Finance/Investors Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NML Finance
- TECH Health Care
- Exchange
- NML Nasdaq
- TECH Nasdaq
- Market Cap
- NML 454.4M
- TECH 8.0B
- IPO Year
- NML N/A
- TECH 1989
- Fundamental
- Price
- NML $8.53
- TECH $50.25
- Analyst Decision
- NML
- TECH Buy
- Analyst Count
- NML 0
- TECH 8
- Target Price
- NML N/A
- TECH $81.14
- AVG Volume (30 Days)
- NML 219.3K
- TECH 2.3M
- Earning Date
- NML 01-01-0001
- TECH 05-07-2025
- Dividend Yield
- NML 9.75%
- TECH 0.64%
- EPS Growth
- NML N/A
- TECH N/A
- EPS
- NML N/A
- TECH 0.98
- Revenue
- NML N/A
- TECH $1,196,016,000.00
- Revenue This Year
- NML N/A
- TECH $8.19
- Revenue Next Year
- NML N/A
- TECH $8.61
- P/E Ratio
- NML N/A
- TECH $51.28
- Revenue Growth
- NML N/A
- TECH 4.46
- 52 Week Low
- NML $6.09
- TECH $46.44
- 52 Week High
- NML $7.33
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- NML 52.15
- TECH 41.02
- Support Level
- NML $8.19
- TECH $49.15
- Resistance Level
- NML $8.50
- TECH $53.54
- Average True Range (ATR)
- NML 0.35
- TECH 2.94
- MACD
- NML 0.06
- TECH 0.37
- Stochastic Oscillator
- NML 96.37
- TECH 51.02
About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.
Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.